Stiolto Respimat Inhalation Spray (generic names: tiotropium & olodaterol) is prescribed for long-term use to control symptoms of chronic obstructive pulmonary disease (COPD) in adults.
COPD is a chronic lung disease caused by chronic bronchitis, emphysema, or both. There is no cure for COPD. Stiolto’s role is to improve lung function and reduce the risk of flare-ups. It does not contain steroids. Tiotropium is a long-acting muscarinic antagonist (LAMA), and olodaterol is a long-acting β2-adrenergic agonist (LABA). The two medicines combine to open the airways and make breathing easier.
Stiolto inhalation spray is not meant for the treatment of acute attacks of breathing difficulties in people with COPD. There are rescue medicines (bronchodilators) that treat such sudden symptoms.
Dosage
Follow the doctor’s instructions. The usual dose is two puffs once each day.
This text is for informational purposes only. Please consult your doctor or pharmacist before using any medication.
Side effects may include:
- Headache
- Cough
- Dizziness
- Rapid heart rate
- Hoarseness
- Dry mouth
If these persist or worsen, talk to a doctor or pharmacist.
Stop treatment with Stiolto and call 911 or contact a doctor immediately if any of the following side effects are felt:
- Allergic reaction. It can be experienced as an anaphylactic reaction or individual reactions such as sudden trouble breathing, swelling of mouth and face, rash, and hypersensitivity reactions
- Tightness in the chest with shortness of breath, wheezing, and coughing immediately after inhalation
- Absence of bowel movements or blockage in the intestine
- Seeing colored images or halos around lights in association with red eyes.
Not all side effects are listed here. Before using Stiolto, it is advised to refer to the manufacturer’s product insert that comes with this medication.
Stiolto is indicated for treating chronic obstructive pulmonary disease (COPD) symptoms. The causes of COPD include chronic bronchitis and emphysema. Stiolto helps open the airways to allow proper airflow into and out of the lungs. Stiolto is a long-term treatment that, if taken daily, can help with shortness of breath caused by COPD and minimize its effects.